Condition

HIV

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 1,800 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1,800

Recruiting147

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)NCT07665372 · 2026-11-01

A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesNCT07569029 · 2026-09-15

Prison-Based HIV Partner NotificationNCT07103928 · 2026-09-04

Reducing Stigma and Building Employability Skills for Young People With HIV in ZambiaNCT07732660 · 2026-09-03

BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIVNCT07502365 · 2026-07-29

B-PaLMZ for TB MeningitisNCT07227779 · 2026-07-28

Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South AfricaNCT07703891 · 2026-07-27

Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB TransmissionNCT07628140 · 2026-07-14

Small Trial of Alendronate Impact on the Reservoir of HIVNCT07216794 · 2026-07-08

Cabotegravir-Hormone PK/PD Interactions for HIV PreventionNCT07672717 · 2026-07-07

Project SHIELD 2.0: Police Education to Support Public Health in KentuckyNCT07804121 · 2026-06-25

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidENCT07476339 · 2026-06-17

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entryNCT07136363 · 2026-06-01

Bringing Medicines for HIV Prevention to a Family Planning ClinicNCT06930508 · 2026-05-28

Implementing Depression and Adherence TreatmentNCT07032363 · 2026-05-20

Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based ApproachNCT07574619 · 2026-05-13

Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual MenNCT07762066 · 2026-05-06

CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSMNCT07213258 · 2026-04-24

The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in WomenNCT07284082 · 2026-04-17

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVNCT07221214 · 2026-04-17

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIVNCT07226128 · 2026-04-10

Behavioral Risk Identification and Decision Guidance for HIV EngagementNCT07439003 · 2026-03-27

Streamlining Telehealth for Expanded PrEP Utilization Through Community PartnershipsNCT07246057 · 2026-03-26

Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIVNCT07390474 · 2026-03-25

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1NCT07390955 · 2026-03-19

Peer-led Implementation of TB-HIV Education and Adherence Counseling in UgandaNCT05917210 · 2026-03-16

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject DrugsNCT07199335 · 2026-02-24

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing PainNCT07270406 · 2026-02-16

Care Disengagement Prevention in PLWH in IndonesiaNCT07706634 · 2026-02-11

PrOTECT AL: PrEP Optimization Through Enhanced Continuum TrackingNCT07231640 · 2026-02-09

Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected IndividualsNCT07433387 · 2026-01-29

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 SemaglutideNCT07040592 · 2026-01-15

HIV Suicide Prevention With AI-DBTNCT07339189 · 2026-01-07

Reducing Mobility-associated Interruption in HIV Treatment in MalawiNCT07329166 · 2025-12-18

IBIS Megastudy of Interventions to Encourage HIV RetestingNCT06971367 · 2025-12-09

Ongoing Dynamic Choice to Address HIV Treatment Interruption in MalawiNCT07220278 · 2025-11-17

Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in GhanaNCT06800664 · 2025-11-11

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young AdultsNCT06444360 · 2025-11-04

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.NCT06900829 · 2025-10-01

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-careNCT06850402 · 2025-09-22

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentNCT06497465 · 2025-09-18

The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) StudyNCT06743204 · 2025-09-08

Combination Vaccination and Broadly Neutralising Antibody Therapy in HIVNCT07054931 · 2025-09-05

Mentor Moms+ StudyNCT06962592 · 2025-09-01

We-INtervention Among Chinese HIV-serodiscordant Male CouplesNCT06639932 · 2025-09-01

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS PatientsNCT06880380 · 2025-09-01

A Pilot Project for PLWH Aged 65-75: Preventing the Development of FrailtyNCT07486661 · 2025-08-28

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIVNCT07105007 · 2025-08-15

Questioning the Epidemiology of Asymptomatic TBNCT07312266 · 2025-08-11

Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)NCT06967753 · 2025-07-31

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)NCT07170748 · 2025-07-29

A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.NCT06617091 · 2025-07-28

HomeLink2: Reducing Posthospitalization Mortality Through Structured Home Care and Nutritional SupportNCT07102745 · 2025-07-24

A Study to Improve Skeletal Muscle in Veterans With HIVNCT06845046 · 2025-07-15

Project Vuselela FeasibilityNCT07117656 · 2025-07-13

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in LilongweNCT06770101 · 2025-07-01

Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young WomenNCT06953310 · 2025-05-20

Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of CameroonNCT07181278 · 2025-04-28

Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority MenNCT06894199 · 2025-04-22

Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot StudyNCT06955715 · 2025-04-15

Common interventions

Leading sponsors

University of California, San Francisco 63 National Institute of Allergy and Infectious Diseases (NIAID) 62 University of North Carolina, Chapel Hill 59 Emory University 34 Yale University 30 Massachusetts General Hospital 29 University of Washington 29 Johns Hopkins University 28 Columbia University 27 University of California, Los Angeles 27 St Stephens Aids Trust 26 Boston University 24 Duke University 23 University of Alabama at Birmingham 23 University of Pennsylvania 22

Trial status mix

COMPLETED1,218

UNKNOWN167

RECRUITING147

NOT_YET_RECRUITING81

TERMINATED63

ACTIVE_NOT_RECRUITING62

WITHDRAWN34

ENROLLING_BY_INVITATION21

NO_LONGER_AVAILABLE3

SUSPENDED3

APPROVED_FOR_MARKETING1

Phase mix

NA825

PHASE2203

PHASE1176

PHASE4159

PHASE3115

EARLY_PHASE19

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.